| LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |
| ECT |
|
centralopathic epilepsy
|
|
|
0.626 |
0.423 |
| H3P19 |
|
H3 histone pseudogene 19
|
|
|
0.631 |
0.577 |
| FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
| FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
| SNORD116@ |
|
small nucleolar RNA, C/D box 116 cluster
|
|
|
0.705 |
0.692 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| FMR1-IT1 |
|
FMR1 intronic transcript 1
|
|
|
0.716 |
0.385 |
| DAOA-AS1 |
|
DAOA antisense RNA 1
|
|
|
0.729 |
0.154 |
| PTLS |
|
Potocki-Lupski syndrome
|
|
|
0.780 |
0.308 |
| TEMPS |
|
Temple syndrome
|
|
|
0.780 |
0.154 |
| DISC1FP1 |
|
DISC1 fusion partner 1
|
|
|
0.931 |
0.038 |
| PRG1 |
|
p53-responsive gene 1
|
|
|
0.839 |
0.231 |
| ABCB10P1 |
|
ABCB10 pseudogene 1
|
|
|
0.839 |
0.231 |
| SCZD12 |
|
schizophrenia 12
|
|
|
0.839 |
0.269 |
| FRA16E |
|
fragile site, distamycin A type, rare, fra(16)(p12.1)
|
|
|
0.931 |
0.077 |
| MACROD2 |
A1Z1Q3
|
mono-ADP ribosylhydrolase 2
|
|
0.43 |
0.686 |
0.423 |
| PSD |
A5PKW4
|
pleckstrin and Sec7 domain containing
|
|
0.90 |
0.626 |
0.654 |
| POTEM |
A6NI47
|
POTE ankyrin domain family member M
|
|
3.2E-04 |
0.541 |
0.769 |
| USP27X |
A6NNY8
|
ubiquitin specific peptidase 27 X-linked
|
|
0.92 |
0.705 |
0.462 |
| PRNP |
F7VJQ1 P04156
|
prion protein
|
|
6.3E-04 |
0.445 |
0.923 |
| ACOT7 |
O00154
|
acyl-CoA thioesterase 7
|
Enzyme
|
0.76 |
0.531 |
0.769 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |